The Indonesian Institute of Sciences (LIPI) has been conducting clinical trials of herbal medicines to cure COVID-19 patients.
The clinical trials took place at the Wisma Athletes Emergency Hospital for COVID-19 Patients in Kemayoran on June 8.
Two herbal medicines are used: Cordyceps militaris and a combination of herbs. The LIPI research team have done the clinical trials on 90 COVID-19 patients in three groups.
Also read: Indonesian Economy Projected to Shrink 3.9 percent If Second Wave Hits
A LIPI researcher Masteria Yunovilsa Putra said that the clinical trials on the COVID-19 patients use the herbal products from native plants of Indonesia and later patients are recommended to consume the products three times a day.
Masteria hoped that the clinical trials will be completed in two months.
He said that Cordyceps militaris is a type of fungus. “It is usually used to increase the immune system and respiratory tract,” Masteria told Kompas.com on Friday (June 12).
Also read: ASEAN Streamlines Southeast Asia Travel Promotion and Covid-19 Updates
Meanwhile, he further added, the herbal medicine contains immunomodulatory substances that can affect the immune system. It has a suppressing effect, or also called immunosuppressants, and has an effect on increasing immune responses, or known as an immunostimulant, or causes the tissue to become unresponsive to an antigen, or tolerogenic.
“This herbal medicine can increase the immune system of the COVID-19 patients, so hopefully the healing process can be faster,” he said.